News


All News

Washington - Dermatologists and manufacturers say dermal fillers are safe and effective, despite a recent recommendation by a Food and Drug Administration (FDA) advisory panel that labeling be revised to include stronger warnings about possible complications.

"In July 2008, we were elated to learn that Congress had reversed the 10.6 percent cut in the Medicare conversion factor scheduled for the second half of that year. Even better, Congress added a 1.1 percent increase - in lieu of the mandated 15.1 percent cut - for 2009 in the Medicare Improvement for Patients and Providers Act of 2008 (MIPPA). "

Psoriasis patients treated for many years with PUVA therapy may be more susceptible to develop cutaneous carcinomas, such as basal cell carcinoma, especially when combined with short regimens of cyclosporine A. Physicians who must turn to this combination regimen in therapy-resistant psoriasis patients should be aware of the possible increased risk for the development of skin cancers in these patients.

Today, many consumers are choosing to fight aging from the inside by using nutricosmetics, such as drinks, supplements and foods that claim to slow the visible signs of aging. But some precautions are in order, according to one expert.

Both ablative and nonablative technologies can rejuvenate the skin. They can also be used to treat acne scarring. Nonablative technologies like intense pulsed light can treat brown spots and control redness associated with rosacea.

Unusual and rare presentations of tinea capitis can sometimes mimic cicatricial alopecia. According to one expert, it is important to consider all possible diagnoses and especially rule out a fungal scalp disease, no matter how suspicious the clinical presentation may be.

Arlington, Va. - Little is known about the obscure disease group of alopecias known as cicatricial alopecia, or scarring alopecia, and to date, an effective therapy for this hair loss disease group largely remains elusive. According to one expert in the field, diagnosing the disease early is key to halting or slowing the progression of the hair loss.